Efficacy of tumor necrosis factor alpha blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment

Arthritis Rheum. 2008 Feb 15;59(2):291-6. doi: 10.1002/art.23337.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage*
  • Antibodies, Monoclonal / administration & dosage*
  • Biopsy
  • Drug Resistance
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G / administration & dosage
  • Immunosuppressive Agents / administration & dosage
  • Infliximab
  • Male
  • Receptors, Tumor Necrosis Factor / administration & dosage
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Vasculitis, Central Nervous System / drug therapy*
  • Vasculitis, Central Nervous System / pathology

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Etanercept